Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy)

Significant proportion of patients with dermatological disorders are on immunosuppressive or immunomodulatory therapy predisposing them to risk of acquisition of COVID-19 infection. However, the efficacy of COVID-19 vaccination among these patients is a matter of concern due to lack of adequate evid...

Descripción completa

Detalles Bibliográficos
Autores principales: Munisamy, Malathi, Singh, Bhabani S. T. P., Pandhi, Deepika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664172/
https://www.ncbi.nlm.nih.gov/pubmed/34976876
http://dx.doi.org/10.4103/idoj.idoj_412_21
_version_ 1784613790607736832
author Munisamy, Malathi
Singh, Bhabani S. T. P.
Pandhi, Deepika
author_facet Munisamy, Malathi
Singh, Bhabani S. T. P.
Pandhi, Deepika
author_sort Munisamy, Malathi
collection PubMed
description Significant proportion of patients with dermatological disorders are on immunosuppressive or immunomodulatory therapy predisposing them to risk of acquisition of COVID-19 infection. However, the efficacy of COVID-19 vaccination among these patients is a matter of concern due to lack of adequate evidence for their protective effect owing to the drug induced immunosuppressed state. Hence, we from the IADVL academy have framed the recommendations to be followed for COVID-19 vaccination among dermatological patients on immunosuppressive therapy based on available related literature.
format Online
Article
Text
id pubmed-8664172
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-86641722021-12-30 Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy) Munisamy, Malathi Singh, Bhabani S. T. P. Pandhi, Deepika Indian Dermatol Online J Review Article Significant proportion of patients with dermatological disorders are on immunosuppressive or immunomodulatory therapy predisposing them to risk of acquisition of COVID-19 infection. However, the efficacy of COVID-19 vaccination among these patients is a matter of concern due to lack of adequate evidence for their protective effect owing to the drug induced immunosuppressed state. Hence, we from the IADVL academy have framed the recommendations to be followed for COVID-19 vaccination among dermatological patients on immunosuppressive therapy based on available related literature. Wolters Kluwer - Medknow 2021-11-25 /pmc/articles/PMC8664172/ /pubmed/34976876 http://dx.doi.org/10.4103/idoj.idoj_412_21 Text en Copyright: © 2021 Indian Dermatology Online Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Munisamy, Malathi
Singh, Bhabani S. T. P.
Pandhi, Deepika
Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy)
title Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy)
title_full Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy)
title_fullStr Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy)
title_full_unstemmed Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy)
title_short Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy)
title_sort recommendations for covid vaccination for dermatological patients on immunosuppressive/immunomodulatory therapy (iadvl academy)
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664172/
https://www.ncbi.nlm.nih.gov/pubmed/34976876
http://dx.doi.org/10.4103/idoj.idoj_412_21
work_keys_str_mv AT munisamymalathi recommendationsforcovidvaccinationfordermatologicalpatientsonimmunosuppressiveimmunomodulatorytherapyiadvlacademy
AT singhbhabanistp recommendationsforcovidvaccinationfordermatologicalpatientsonimmunosuppressiveimmunomodulatorytherapyiadvlacademy
AT pandhideepika recommendationsforcovidvaccinationfordermatologicalpatientsonimmunosuppressiveimmunomodulatorytherapyiadvlacademy

Ejemplares similares